ATE364610T1 - Kristalline polymorphe form von irinotecan- hyrochlorid - Google Patents
Kristalline polymorphe form von irinotecan- hyrochloridInfo
- Publication number
- ATE364610T1 ATE364610T1 AT03743335T AT03743335T ATE364610T1 AT E364610 T1 ATE364610 T1 AT E364610T1 AT 03743335 T AT03743335 T AT 03743335T AT 03743335 T AT03743335 T AT 03743335T AT E364610 T1 ATE364610 T1 AT E364610T1
- Authority
- AT
- Austria
- Prior art keywords
- hyrochloride
- irinotecan
- polymorphous form
- crystalline polymorphous
- crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36068402P | 2002-03-01 | 2002-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE364610T1 true ATE364610T1 (de) | 2007-07-15 |
Family
ID=27789001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03743335T ATE364610T1 (de) | 2002-03-01 | 2003-02-26 | Kristalline polymorphe form von irinotecan- hyrochlorid |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1487840B1 (de) |
| JP (1) | JP2005525367A (de) |
| KR (1) | KR20040091083A (de) |
| CN (1) | CN1276923C (de) |
| AR (1) | AR038618A1 (de) |
| AT (1) | ATE364610T1 (de) |
| AU (1) | AU2003215594A1 (de) |
| BR (1) | BR0308133A (de) |
| CA (1) | CA2477926A1 (de) |
| DE (1) | DE60314378T2 (de) |
| DK (1) | DK1487840T3 (de) |
| ES (1) | ES2287495T3 (de) |
| HK (1) | HK1075044A1 (de) |
| IL (1) | IL163820A0 (de) |
| MX (1) | MXPA04008484A (de) |
| NO (1) | NO20044138L (de) |
| NZ (1) | NZ534999A (de) |
| PE (1) | PE20030923A1 (de) |
| PL (1) | PL372318A1 (de) |
| PT (1) | PT1487840E (de) |
| RU (1) | RU2300535C2 (de) |
| TW (1) | TWI270374B (de) |
| WO (1) | WO2003074527A1 (de) |
| ZA (1) | ZA200406927B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2516643C (en) * | 2003-02-25 | 2011-04-19 | Kabushiki Kaisha Yakult Honsha | Method for preparing polymorphism of irinotecan hydrochloride |
| ES2245891B1 (es) * | 2004-07-09 | 2006-11-16 | Clinmet S.L. | "metodo para la obtencion de un excipiente universal para la administracion oral de principios activos farmaceuticos y composiciones de excipientes resultantes del metodo". |
| BRPI0515832A (pt) | 2004-12-21 | 2008-08-05 | Sigma Tau Ind Farmaceuti | processo estereosseletivo e formas cristalinas de uma camptotecina |
| ATE446299T1 (de) | 2005-02-07 | 2009-11-15 | Fermion Oy | Verfahren zur herstellung von 7-ethyl-10- hydroxycamptothecin |
| WO2006084940A1 (en) | 2005-02-08 | 2006-08-17 | Fermion Oy | Process for producing [1,4'] bipiperidinyl-1'-carbonyl chloride or hydrochloride thereof |
| US7767813B2 (en) | 2005-02-08 | 2010-08-03 | Fermion Oy | Preparation method |
| JP5119153B2 (ja) * | 2005-09-20 | 2013-01-16 | シノファーム シンガポール ピーティーイー，リミテッド | イリノテカン塩酸塩の新規結晶形 |
| CN101318964B (zh) * | 2007-06-07 | 2010-12-15 | 上海迪赛诺医药发展有限公司 | 盐酸伊立替康新晶型及其制备方法 |
| FR2918279B1 (fr) * | 2007-07-05 | 2010-10-22 | Aventis Pharma Sa | Combinaisons antitumorales contenant un agent inhibiteur de vegf et de l'irinotecan |
| IT1391757B1 (it) * | 2008-11-11 | 2012-01-27 | Antibioticos Spa | Irinotecan cloridrato cristallino e metodi per la sua preparazione |
| CN101659667B (zh) * | 2009-09-07 | 2011-11-02 | 重庆泰濠制药有限公司 | 一种盐酸伊立替康的纯化方法 |
| US8546573B2 (en) | 2009-11-18 | 2013-10-01 | Cadila Healthcare Limited | Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperdino] carbonyloxy-camptothecin hydrochloride trihydrate |
| JO3283B1 (ar) | 2011-04-26 | 2018-09-16 | Sanofi Sa | تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI) |
| CN102866126B (zh) * | 2011-07-05 | 2016-03-23 | 重庆华邦制药有限公司 | 一种定量测定化合物中晶型比例的方法 |
| CN102311443B (zh) * | 2011-08-24 | 2014-07-16 | 上海北卡医药技术有限公司 | 盐酸伊立替康的新晶型及其制备方法 |
| RU2529831C2 (ru) * | 2012-11-30 | 2014-09-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Российский университет дружбы народов" (РУДН) | Способ лечения рака толстой кишки |
| MA40354A (fr) | 2014-07-18 | 2017-05-24 | Sanofi Sa | Procédé permettant de prédire le résultat d'un traitement avec de l'aflibercept d'un patient suspecté de souffrir d'un cancer |
| KR102293907B1 (ko) * | 2015-06-30 | 2021-08-26 | 한미약품 주식회사 | 이리노테칸 함유 경구용 고형제제 및 그 제조방법 |
| KR102066402B1 (ko) * | 2017-12-22 | 2020-01-15 | 대화제약 주식회사 | 이리노테칸 또는 그의 약제학적으로 허용가능한 염을 포함하는 경구투여용 약제학적 조성물 |
| US10919905B2 (en) | 2019-05-16 | 2021-02-16 | Scinopharm Taiwan, Ltd. | Polymorphism for irinotecan free base |
-
2003
- 2003-02-26 EP EP03743335A patent/EP1487840B1/de not_active Expired - Lifetime
- 2003-02-26 RU RU2004129307/04A patent/RU2300535C2/ru not_active IP Right Cessation
- 2003-02-26 MX MXPA04008484A patent/MXPA04008484A/es not_active Application Discontinuation
- 2003-02-26 AT AT03743335T patent/ATE364610T1/de not_active IP Right Cessation
- 2003-02-26 CA CA002477926A patent/CA2477926A1/en not_active Abandoned
- 2003-02-26 AU AU2003215594A patent/AU2003215594A1/en not_active Abandoned
- 2003-02-26 CN CNB038072726A patent/CN1276923C/zh not_active Expired - Fee Related
- 2003-02-26 KR KR10-2004-7013621A patent/KR20040091083A/ko not_active Application Discontinuation
- 2003-02-26 NZ NZ534999A patent/NZ534999A/en unknown
- 2003-02-26 BR BR0308133-8A patent/BR0308133A/pt not_active IP Right Cessation
- 2003-02-26 JP JP2003572995A patent/JP2005525367A/ja not_active Withdrawn
- 2003-02-26 PL PL03372318A patent/PL372318A1/xx not_active Application Discontinuation
- 2003-02-26 ES ES03743335T patent/ES2287495T3/es not_active Expired - Lifetime
- 2003-02-26 PT PT03743335T patent/PT1487840E/pt unknown
- 2003-02-26 IL IL16382003A patent/IL163820A0/xx unknown
- 2003-02-26 DE DE60314378T patent/DE60314378T2/de not_active Expired - Fee Related
- 2003-02-26 WO PCT/EP2003/001948 patent/WO2003074527A1/en active IP Right Grant
- 2003-02-26 DK DK03743335T patent/DK1487840T3/da active
- 2003-02-27 TW TW092104194A patent/TWI270374B/zh not_active IP Right Cessation
- 2003-02-28 AR ARP030100656A patent/AR038618A1/es unknown
- 2003-02-28 PE PE2003000196A patent/PE20030923A1/es not_active Application Discontinuation
-
2004
- 2004-08-31 ZA ZA200406927A patent/ZA200406927B/en unknown
- 2004-09-29 NO NO20044138A patent/NO20044138L/no not_active Application Discontinuation
-
2005
- 2005-08-22 HK HK05107303A patent/HK1075044A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2004129307A (ru) | 2005-04-10 |
| JP2005525367A (ja) | 2005-08-25 |
| CN1276923C (zh) | 2006-09-27 |
| NZ534999A (en) | 2007-03-30 |
| BR0308133A (pt) | 2005-01-04 |
| KR20040091083A (ko) | 2004-10-27 |
| DK1487840T3 (da) | 2007-07-16 |
| ES2287495T3 (es) | 2007-12-16 |
| DE60314378D1 (en) | 2007-07-26 |
| WO2003074527A1 (en) | 2003-09-12 |
| AR038618A1 (es) | 2005-01-19 |
| NO20044138L (no) | 2004-11-29 |
| AU2003215594A1 (en) | 2003-09-16 |
| TWI270374B (en) | 2007-01-11 |
| PL372318A1 (en) | 2005-07-11 |
| EP1487840A1 (de) | 2004-12-22 |
| ZA200406927B (en) | 2006-06-28 |
| PT1487840E (pt) | 2007-09-11 |
| IL163820A0 (en) | 2005-12-18 |
| CA2477926A1 (en) | 2003-09-12 |
| TW200303753A (en) | 2003-09-16 |
| CN1642958A (zh) | 2005-07-20 |
| DE60314378T2 (de) | 2008-02-28 |
| RU2300535C2 (ru) | 2007-06-10 |
| MXPA04008484A (es) | 2004-12-06 |
| PE20030923A1 (es) | 2003-10-29 |
| HK1075044A1 (en) | 2005-12-02 |
| EP1487840B1 (de) | 2007-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE364610T1 (de) | Kristalline polymorphe form von irinotecan- hyrochlorid | |
| ATE368042T1 (de) | Cephemverbindungen | |
| FI20021262A (fi) | Sokerien kiteytys | |
| DK1522539T3 (da) | Krystallinsk komposition indeholdende excitalopram | |
| ATE428701T1 (de) | Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2- | |
| DE10393374D2 (de) | Zusammensetzung | |
| NO20044046L (no) | Substituerte hydroksyetylaminer | |
| IS7381A (is) | Efnasambönd | |
| EP1559433A4 (de) | Stabilisierte zusammensetzung | |
| IS7414A (is) | Oxó-azabísýklísk efnasambönd | |
| DE60321190D1 (de) | Knopf | |
| DE60327447D1 (de) | Pflaster | |
| NO20045659L (no) | Forbindelser | |
| IS7827A (is) | Ný efnasambönd | |
| SE0500163L (sv) | Sammansättning | |
| ATE496887T1 (de) | Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide | |
| IS7833A (is) | Efnasambönd með sameinaða heteróhringi | |
| EP1561467A4 (de) | Zusammensetzung zur wiederherstellung geschädigter haut | |
| DE50202991D1 (de) | Hochtemperaturfestes Klebemittel | |
| NO20055097D0 (no) | Krystallinske N-formyl-hydroksylaminforbindelser | |
| NO20044140D0 (no) | New Composition | |
| NO20044364L (no) | Hydroksykarbamimidoyl-2-hydroksy-benzensulfonamidderivat-krystaller | |
| ATE350379T1 (de) | Substituierte benzdioxepine | |
| EP1498386A4 (de) | Mikrofeine selbstaggregierte einheit | |
| ATE410417T1 (de) | Kristallmodifikationen von triazinylaminostilbenen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1487840 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |